Sera Prognostics, Inc. (SERA)
2.03
-0.04
(-1.93%)
USD |
NASDAQ |
Oct 13, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Sera Prognostics Free Cash Flow : -28.18M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.18M |
| March 31, 2026 | -27.58M |
| December 31, 2025 | -26.35M |
| September 30, 2025 | -26.22M |
| June 30, 2025 | -26.95M |
| March 31, 2025 | -27.13M |
| December 31, 2024 | -15.29M |
| September 30, 2024 | -15.75M |
| June 30, 2024 | -16.05M |
| March 31, 2024 | -18.11M |
| December 31, 2023 | -27.32M |
| September 30, 2023 | -27.97M |
| Date | Value |
|---|---|
| June 30, 2023 | -29.50M |
| March 31, 2023 | -30.76M |
| December 31, 2022 | -35.40M |
| September 30, 2022 | -37.87M |
| June 30, 2022 | -38.45M |
| March 31, 2022 | -35.51M |
| December 31, 2021 | -32.94M |
| September 30, 2021 | -27.27M |
| June 30, 2021 | -21.55M |
| March 31, 2021 | -19.38M |
| December 31, 2020 | -17.02M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Myriad Genetics, Inc. | -14.20M |
| BioRestorative Therapies, Inc. | -11.90M |
| CareDx, Inc. | 84.03M |
| Natera, Inc. | 51.20M |
| Exagen, Inc. | -7.588M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.311M |
| Cash from Investing (Quarterly) | 6.394M |
| Cash from Financing (Quarterly) | 0.14M |
| Free Cash Flow Per Share (Quarterly) | -0.1261 |
| Free Cash Flow to Equity (Quarterly) | -6.859M |
| Free Cash Flow to Firm (Quarterly) | -6.361M |
| Free Cash Flow Yield | -27.73% |